American Academy of Neurology (AAN) Guideline Summary for Clinicians: Evaluation of the Child with Global Developmental Delay

QualityTool

American Academy of Neurology (AAN) Guideline Summary for Clinicians: Evaluation of the Child with Global Developmental Delay

Description

This two-page tool is a summary of the American Academy of Neurology and Child Neurology Society guideline on diagnosis of the child with global developmental delay. This practice parameter reviewed available evidence concerning the value of diagnostic testing in the initial evaluation of a young child with a global developmental delay that is static and nonprogressive and has no clear etiology.

This summary presents specific recommendations for each of the following testing modalities:

  • Metabolic screening
  • Cytogenetic testing
  • Fragile X testing
  • Rett syndrome testing
  • Molecular techniques
  • Lead screening
  • Thyroid screening
  • Electroencephalography
  • Neuroimaging
  • Hearing and vision testing

This tool includes a flowchart to guide the diagnostic process.

Developer:

American Academy of Neurology; Child Neurology Society

Funding Sources:

American Academy of Neurology

History

Release Date: 2003
Original Summary: September 2004
Last Updated: 07/31/13

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.